Prof Mike Chan Tells London Conference Longevity Must Mean Living Well, Not Just Living Longer

LONDON, April 19, 2026 — Prof. Mike Chan brought his message of precision regenerative medicine to London this week, telling delegates at Wigmore Presents 2026 that the future of longevity care lies not in chasing years alone, but in preserving the function of the body’s organs and systems as they age.

Chan, founder and chairman of European Wellness Biomedical Group, was featured in the conference programme at the Royal College of Physicians, where he delivered a keynote session on April 17 under the title, “My 40+ Year Journey with Stem Cells & Peptide Therapy in Regenerative & Longevity Medicine.” The event ran from April 17 to 19 and included sessions on regenerative medicine, skincare, devices and injectables.

A Call to Rethink Aging

During his presentation, Chan argued that aging should be understood as a process of organ decline rather than simply the passing of time, a theme that has become central to his public lectures on healthspan and regenerative medicine. In one of his best-known lines, he says, “Longevity means nothing without Healthspan.”

He has repeatedly framed the issue in practical terms for medical and wellness audiences, asking:

 “What’s the point of living long if you are not healthy? What’s the point of reaching 100 or even 120 if you’re already bedridden at 75?”

During the London lecture, Chan addressed a packed auditorium beneath slides charting when different parts of the body begin to age, from arteries and heart function to brain regions, muscles, bones and endocrine glands. The emphasis, both visually and in his wider body of work, was on intervening earlier and more precisely.

Precision, Not One-size-fits-all Treatment

Prof. Mike Chan has long argued that regenerative medicine must move away from generalized treatment models and toward organ-specific and function-specific targeting.

In earlier conference remarks reflected in the source material, he put it this way:

“You give A1 for A1 disease, B6 for B6 disease, Z10 for Z10 disease. You cannot give ‘A’ and claim it treats diabetes, autism, Alzheimer’s, Parkinson’s, cancer and everything else. Bio-regenerative medicine is about specificity and precision.”

That same philosophy appears to have shaped his London lecture, where the projected slides focused on when specific organs start to deteriorate and why, in his view, treatment must match the biological needs of each system rather than rely on a one-size-fits-all formula.

He has also said:

“Most organs don’t last 75 years, let alone 120,”

underscoring his argument that the challenge is not merely extending life, but maintaining function for as long as possible.

Regenerative medicine enters the mainstream conference circuit

Wigmore Presents described its 2026 meeting as a gathering of influential industry experts, while outside coverage of the event highlighted Chan’s session as one exploring stem cells, exosomes and peptide therapies for tissue repair and healthy ageing.

His appearance there reflects a broader shift in which regenerative medicine is increasingly being discussed alongside aesthetics, preventive care and performance medicine.

Prof. Mike Chan has presented that shift as both scientific and personal. “The goal isn’t to make you dependent on external interventions forever,” he said in one of the source materials.

“The goal is to restore your body’s own regenerative capacity. To give your cells what they need to repair themselves.”

For London delegates, the takeaway was consistent with the message he has delivered across recent summits: longer life, he argues, is meaningful only if the body and brain remain capable of sustaining quality of life.

The session also drew warm feedback from attendees, with Dr. Ebru Ünal calling Prof. Mike Chan’s lecture “very good and inspiring,” and saying she plans to attend the upcoming conference in Malaysia at the end of July 2026.